文献速递冠心病

COVID-19大流行对ST段抬高型心肌梗死直接PCI及30天死亡率的影响

COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.
PubMed 文献 · Heart · 2021-10-28

结果显示2020年直接PCI显著减少(发生率比0.843),治疗延迟增加,住院及30天死亡率升高。

要点

  • 大流行期间直接PCI发生率较2019年下降16%,老年患者(>75岁)下降更明显。
  • 门-球时间及总缺血时间显著延长,可能贡献于死亡率升高。
  • 住院死亡率6.5% vs 5.3%,30天死亡率8% vs 6.5%,均显著增加。

核心结论

  • COVID-19大流行显著影响STEMI的直接PCI治疗,PCI减少16%,老年患者约减少20%,治疗延迟延长,可能贡献于住院和30天死亡率增加。

主要发现

  • 2020年直接PCI发生率较2019年显著降低(发生率比0.843,95%CI 0.825-0.861,p<0.0001)。
  • 直接PCI减少与年龄显著相关,老年(>75岁)患者减少更明显(p=0.015),与COVID-19病例或死亡高峰无关。
  • 中心间异质性高(p<0.001)。
  • 大流行期间门-球时间显著增加(40(25-70)min vs 40(25-64)min,p=0.01)。
  • 总缺血时间显著延长(225(135-410)min vs 196(120-355)min,p<0.001)。

临床怎么用

  • 疫情期间应维持STEMI直接PCI流程,尤其关注老年患者,减少治疗延迟以降低死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The initial data of the International Study on Acute Coronary Syndromes - ST Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction in primary percutaneous coronary intervention procedures and higher in-hospital mortality during the initial phase of the pandemic as compared with the prepandemic period. The aim of the current study was to provide the final results of the registry, subsequently extended outside Europe with a larger inclusion period (up to June 2020) and longer follow-up (up to 30 days). METHODS: This is a retrospective multicentre registry in 109 high-volume primary percutaneous coronary intervention (PPCI) centres from Europe, Latin America, South-East Asia and North Africa, enrolling 16 674 patients with ST segment elevation myocardial infarction (STEMI) undergoing PPPCI in March/June 2019 and 2020. The main study outcomes were the incidence of PPCI, delayed treatment (ischaemia time >12 hours and door-to-balloon >30 min), in-hospital and 30-day mortality. RESULTS: In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio 0.843, 95% CI 0.825 to 0.861, p<0.0001). This reduction was significantly associated with age, being higher in older adults (>75 years) (p=0.015), and was not related to the peak of cases or deaths due to COVID-19. The heterogeneity among centres was high (p<0.001). Furthermore, the pandemic was associated with a significant increase in door-to-balloon time (40 (25-70) min vs 40 (25-64) min, p=0.01) and total ischaemia time (225 (135-410) min vs 196 (120-355) min, p<0.001), which may have contributed to the higher in-hospital (6.5% vs 5.3%, p<0.001) and 30-day (8% vs 6.5%, p=0.001) mortality observed during the pandemic. CONCLUSION: Percutaneous revascularisation for STEMI was significantly affected by the COVID-19 pandemic, with a 16% reduction in PPCI procedures, especially among older patients (about 20%), and longer delays to treatment, which may have contributed to the increased in-hospital and 30-day mortality during the pandemic. TRIAL REGISTRATION NUMBER: NCT04412655.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. De Luca G, Algowhary M, Uguz B, et al. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction. Heart. 2021. PMID: 34711661. doi:10.1136/heartjnl-2021-319750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。